Search Results 81-90 of 22977 for Phase

1. Phase 1 clinical trial testing gene therapy treatment for knee osteoarthritis

   The phase 1 trial involved nine study participants with radiographically confirmed knee OA. The nine participants were divided into three dosage groups (low, ...

2. A Phase 2a Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases - Mayo Clinic

   A Phase 2a Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases · Overview · Participation eligibility · Participating Mayo Clinic ...

3. Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers - Mayo Clinic

   The purpose of Phase Ib is to evaluate the safety and tolerability of the combination of TG4001 plus avelumab in patients with recurrent or metastatic HPV-16 ...

4. Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III - Mayo Clinic

   About this study. A phase III, randomized, case-controlled, open-label, 500-subject clinical trial of minimally invasive surgery plus rt-PA in the treatment ...

5. Phase 3 Study of Vimseltinib for Tenosynovial Giant Cell Tumor - Mayo Clinic

   Part 2 is a long-term treatment phase in which all participants receive open-label vimseltinib. Participation eligibility. Participant eligibility includes age, ...

6. Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III - Mayo Clinic

   The overall objective of this Phase III clinical trial is to obtain information from a population of 500 ICH subjects with intraventricular hemorrhage (IVH), ...

7. Phase Ib Study of Axatilimab in Combination with Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer - Mayo Clinic

   Phase Ib Study of Axatilimab in Combination with Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer · More about research at Mayo ...

8. Phase 2 Study of VGT-309 in Lung Cancer - Mayo Clinic

   The purpose of this study is to evaluate safety and efficacy of VGT-309 to identify cancer in up to 40 subjects undergoing lung cancer surgery. Participation ...

9. A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 In Healthy Participants And Participants With Mild-to-Moderate Asthma - Mayo Clinic

   A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 In Healthy Participants And Participants With Mild-to-Moderate Asthma · Overview.

10. A Phase I study of Epalrestat Therapy in a Single Patient with Phosphomannomutase Deficiency (PMM2-CDG) - Mayo Clinic

    A Phase I study of Epalrestat Therapy in a Single Patient with Phosphomannomutase Deficiency (PMM2-CDG). Print details. Share; Facebook · Twitter.